Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 921 1810

Fax: 604 921 1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

TopCharts May. 15 at 2:48 PM

$BCTX broke below 3.60s and is looking for new bottom. Is dilution on horizon? Lots of news pump usually is followed by capital raise here.

0 · Reply

ColeCapInvests May. 15 at 2:41 PM

$BCTX Technical Bounce Education Time for all you newbies! Watch for the “Long Handle Hammer” forming below this previous support level! I like to call it something else .. A stock that has a very large University of SC Mascot or The Hammer!

1 · Reply

MoeMaze May. 15 at 2:40 PM

$BCTX

0 · Reply

durocali May. 15 at 2:39 PM

$BCTX thats an ugly hook down on the daily chart on no news (??)... something we missed or did short interest just do a bot swarm here?

1 · Reply

MarkeTimer May. 15 at 2:32 PM

$BCTX Don't be tempted on this POS. Another raise and $2 prices forthcoming.

0 · Reply

Susquehanna May. 15 at 2:32 PM

$BCTX

0 · Reply

Orlandotrader May. 15 at 2:30 PM

$BCTX Lots of New PR on new Trials and no up movement Equals more Short Pressure. Nothing new. Got to love the Negativity.

0 · Reply

Manwiththeplan May. 15 at 2:09 PM

$BCTX why -10%?

2 · Reply

JediGreen May. 15 at 2:03 PM

$BCTX

1 · Reply

ColeCapInvests May. 15 at 2:03 PM

$BCTX Just got alerted my buy target price just got filled!! Loading another ship with this save the Big Stocktitties Cancer Killing Beauty! Watch her / them bounce in this area! 😂👀😉$HUMA $SLS $IBRX

3 · Reply

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

Thu, 14 May 2026 07:30:00 -0400 - 1 day ago

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

2026-05-13T14:41:55.000Z - 2 days ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

Wed, 13 May 2026 07:30:00 -0400 - 2 days ago

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Tue, 12 May 2026 07:30:00 -0400 - 3 days ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Thu, 07 May 2026 07:30:00 -0400 - 8 days ago

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

2026-05-07T04:03:56.000Z - 8 days ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

Wed, 06 May 2026 07:30:00 -0400 - 9 days ago

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Mon, 27 Apr 2026 07:30:00 -0400 - 18 days ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

2026-04-21T13:28:43.000Z - 24 days ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T11:54:23.000Z - 24 days ago

BriaCell presents anti-cancer activity of Bria-OTS

Tue, 21 Apr 2026 07:30:00 -0400 - 24 days ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

2026-04-20T13:32:04.000Z - 25 days ago

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

2026-04-20T11:41:56.000Z - 25 days ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

Mon, 20 Apr 2026 07:30:00 -0400 - 25 days ago

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Tue, 31 Mar 2026 16:05:00 -0400 - 6 weeks ago

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

2026-03-18T13:30:56.000Z - 2 months ago

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

2026-03-18T11:42:55.000Z - 2 months ago

BriaCell to present four posters at the 2026 AACR

Wed, 18 Mar 2026 07:30:00 -0400 - 2 months ago

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Tue, 10 Mar 2026 07:30:00 -0400 - 2 months ago

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 2 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

2026-02-18T22:51:30.000Z - 3 months ago

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

2026-02-18T22:35:25.000Z - 3 months ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

Wed, 18 Feb 2026 17:30:00 -0500 - 3 months ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

2026-02-17T12:40:59.000Z - 3 months ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

Tue, 17 Feb 2026 07:30:00 -0500 - 3 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-01-28T13:30:56.000Z - 3 months ago

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment

2026-01-28T12:40:40.000Z - 3 months ago

BriaCell says patient images show regression, resolution of metastsized tumors

Wed, 28 Jan 2026 07:30:00 -0500 - 3 months ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

2026-01-27T13:32:37.000Z - 3 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T12:41:04.000Z - 3 months ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

Tue, 27 Jan 2026 07:30:00 -0500 - 3 months ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

2026-01-19T16:00:45.000Z - 4 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-16T13:58:57.000Z - 4 months ago

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch

Thu, 15 Jan 2026 16:05:00 -0500 - 4 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

2026-01-14T11:36:30.000Z - 4 months ago

What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:19:44.000Z - 4 months ago

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering

2026-01-14T10:55:53.000Z - 4 months ago

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

2026-01-14T06:56:44.000Z - 4 months ago

BriaCell Therapeutics (BCTX) Launches $30M Public Offering

Tue, 13 Jan 2026 21:00:00 -0500 - 4 months ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

2026-01-13T20:32:32.000Z - 4 months ago

BCTX Surges On Positive Clinical Response In Metastatic Cancer Immunotherapy Study

2026-01-13T14:41:11.000Z - 4 months ago

BriaCell Therapeutics trading resumes

2026-01-13T14:35:29.000Z - 4 months ago

BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:08:02.000Z - 4 months ago

BriaCell Surge Above 50%; What's The Buzz?

2026-01-13T12:53:09.000Z - 4 months ago

BriaCell (BCTX) Reports Impressive Lung Metastasis Resolution in Cancer Trial

2026-01-13T12:35:49.000Z - 4 months ago

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

Tue, 13 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Thu, 18 Dec 2025 07:30:00 -0500 - 5 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

2025-12-10T13:29:00.000Z - 5 months ago

BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposium

2025-12-10T12:41:29.000Z - 5 months ago

BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025

Dec 10, 2025, 7:30 AM EST - 5 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

2025-12-09T12:35:35.000Z - 5 months ago

BriaCell announces Phase 3 patient enrollment on track for 1H26 data readout

Dec 9, 2025, 7:30 AM EST - 5 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

2025-12-02T12:36:29.000Z - 5 months ago

BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025

Dec 2, 2025, 7:30 AM EST - 5 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 6 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

2025-11-20T12:40:35.000Z - 6 months ago

BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics

Nov 20, 2025, 7:30 AM EST - 6 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 18, 2025, 7:30 AM EST - 6 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

2025-11-07T12:41:48.000Z - 6 months ago

BriaCell presents anti-cancer activity of Bria-OTS at SITC 2025

Nov 7, 2025, 7:30 AM EST - 6 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 4, 2025, 7:30 AM EST - 6 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

2025-10-22T11:37:13.000Z - 7 months ago

BriaCell says DSMB recommends continuation of Phase 3 Bria-IMT study

Oct 21, 2025, 7:50 AM EDT - 7 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:30 AM EDT - 7 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 20, 2025, 7:30 AM EDT - 7 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 7 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 3, 2025, 7:30 AM EDT - 8 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Aug 26, 2025, 7:30 AM EDT - 9 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 9 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 9 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 9 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 10 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 10 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 10 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 10 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 10 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 10 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 10 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 11 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 10, 2025, 7:30 AM EDT - 11 months ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

Jul 9, 2025, 7:30 AM EDT - 11 months ago

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

Jul 8, 2025, 7:30 AM EDT - 11 months ago

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

Jul 2, 2025, 7:30 AM EDT - 11 months ago

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

TopCharts May. 15 at 2:48 PM

$BCTX broke below 3.60s and is looking for new bottom. Is dilution on horizon? Lots of news pump usually is followed by capital raise here.

0 · Reply

ColeCapInvests May. 15 at 2:41 PM

1 · Reply

MoeMaze May. 15 at 2:40 PM

$BCTX

0 · Reply

durocali May. 15 at 2:39 PM

$BCTX thats an ugly hook down on the daily chart on no news (??)... something we missed or did short interest just do a bot swarm here?

1 · Reply

MarkeTimer May. 15 at 2:32 PM

$BCTX Don't be tempted on this POS. Another raise and $2 prices forthcoming.

0 · Reply

Susquehanna May. 15 at 2:32 PM

$BCTX

0 · Reply

Orlandotrader May. 15 at 2:30 PM

$BCTX Lots of New PR on new Trials and no up movement Equals more Short Pressure. Nothing new. Got to love the Negativity.

0 · Reply

Manwiththeplan May. 15 at 2:09 PM

$BCTX why -10%?

2 · Reply

JediGreen May. 15 at 2:03 PM

$BCTX

1 · Reply

ColeCapInvests May. 15 at 2:03 PM

3 · Reply

Ares77manoe May. 15 at 1:54 PM

$BCTX adding

1 · Reply

Kirubin May. 15 at 1:54 PM

$BCTX 🫢😂☠️🖕🏽🖕🏽JJ

0 · Reply

TopCharts May. 15 at 1:52 PM

$BCTX needs to hold 3.60s otherwise will be going for new bottom

0 · Reply

BioTuesdays May. 15 at 1:10 PM

$BCTX has announced progress in developing Bria-OVA+, its next generation, personalized, off-the-shelf, cell-based immunotherapy for ovarian cancer. https://biotuesdays.com/2026/05/15/briacell-expands-pipeline-to-ovarian-cancer-candidate/

0 · Reply

MarkeTimer May. 15 at 12:02 PM

$BCTX Expanding to raise more money. Dirty AF.

0 · Reply

Wolfe82 May. 15 at 11:48 AM

$BCTX Expands pipeline

0 · Reply

SmallCapVoice May. 15 at 11:37 AM

BriaCell $BCTX is expanding its women’s health pipeline with Bria-OVA+, a next-gen ovarian cancer immunotherapy candidate. With ovarian cancer still the deadliest gynecologic cancer and more than 12,000 U.S. deaths expected in 2026, this could be an important step toward new treatment options. https://www.globenewswire.com/news-release/2026/05/15/3295754/0/en/briacell-expands-pipeline-to-include-an-ovarian-cancer-immunotherapy-candidate-bria-ova.html

0 · Reply

JediGreen May. 15 at 3:58 AM

$BCTX Looks like dumpers are at and blabbering. Phase 3 read out coming. Have fun covering if results are good.

2 · Reply

JediGreen May. 15 at 1:49 AM

$BCTX BCTX Short Volume | ChartExchange https://chartexchange.com/symbol/nasdaq-bctx/short-volume/

0 · Reply

Rohtan May. 15 at 1:15 AM

$BCTX it only know one way. Down

0 · Reply

superguild May. 14 at 7:41 PM

$BCTX RUN FOR THE HILLS. JJ pumping again!!

1 · Reply

JJBurch May. 14 at 4:08 PM

$BGDE $BCTX $QCLS $NRXP These four will see big big gains over the next 3 weeks. No doubt $NIVF This one, however, is set up for a multi bagger in the same time frame. Looking for $3-$5 Enjoy the rest of this month So much money to be made. Especially on these and most notably on NIVF Congrats on our wins in April. Let’s keep it going!!!!

0 · Reply

Market Cap	30.31M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	285,000
Avg Vol	177,182
Day's Range	N/A - N/A
Shares Out	7.25M
Stochastic %K	24%
Beta	1.26
Analysts	Strong Buy
Price Target	$40.00